Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-κB pathways
Bone loss is a major issue for patients with osteoporosis, arthritis, periodontitis, and bone metastasis; however, anti-resorption drugs used to treat bone loss have been linked to a variety of adverse effects. Helminthostachys zeylanica (L.) Hook, belonging to the family Ophioglossaceae, is commonl...
Main Authors: | Chun-Lin Liu, Trung-Loc Ho, Shuen-Yih Fang, Jeng-Hung Guo, Chih-Ying Wu, Yi-Chin Fong, Chih-Chuang Liaw, Chih-Hsin Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223011903 |
Similar Items
-
Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
by: Liuliu Yan, et al.
Published: (2019-06-01) -
Fermented Rice Bran Supplementation Inhibits LPS-Induced Osteoclast Formation and Bone Resorption in Mice
by: Takahiro Noguchi, et al.
Published: (2023-07-01) -
Piperlongumine Inhibits Titanium Particles-Induced Osteolysis, Osteoclast Formation, and RANKL-Induced Signaling Pathways
by: Xuan Liu, et al.
Published: (2022-03-01) -
Osteoclast biology in bone resorption: a review
by: Chao Fu, et al.
Published: (2020-09-01) -
Wheat seedling extract and its constituents attenuate RANKL-induced differentiation and fusion of osteoclasts and bone resorption
by: HanGyeol Lee, et al.
Published: (2023-09-01)